RRC ID 42923
著者 Miyamoto N, Yamamoto H, Taniguchi H, Miyamoto C, Oki M, Adachi Y, Imai K, Shinomura Y.
タイトル Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability.
ジャーナル Cancer Lett
Abstract Gastric cancers with and those without high-frequency microsatellite instability (MSI-H) represent distinctive pathways of carcinogenesis. The aim of this study was to clarify if expression of p53 related genes involved in angiogenesis is differentially regulated between these cancers. We systematically analyzed the expression of vascular endothelial growth factor A (VEGFA), fibroblast growth factor 2 (FGF2), thrombospondin 1 (THBS1), and brain-specific angiogenesis inhibitor 1 (BAI1), and we correlated the results with microvessel count (MVC), MSI status, p53 mutations, and prostaglandin-endoperoxide synthase 2 (PTGS2) expression in gastric cancers. Expression of VEGFA in carcinoma cells was immunohistochemically seen in 46% of 200 cases. VEGFA positivity was significantly associated with higher MVC, vascular invasion, lymph node and distant metastasis, and advanced tumor stage. FGF2 positivity was significantly associated with poor differentiation, depth of invasion, and higher MVC. VEGFA and FGF2 positivities and MVC were lower in MSI-H cancers than in MSI-L or MSS cancers. VEGFA expression was associated with both p53 mutations and PTGS2 expression. Methylation of the THBS1 gene was detected in 6 of 11 cancer cell lines and in 44% of 200 cases. THBS1 methylation was significantly associated with distal location, vascular invasion, distant metastasis, MSI-H, wild-type p53, and higher MVC. The prognosis was worst in patients with cancers that were VEGFA-positive and THBS1 methylation-positive. Gastric cancers with MSI-H were characterized by lower MVC, low frequency of VEGFA, FGF2, and PTGS2 overexpression, and high frequency of THBS1 methylation. Our results suggest that gastric cancers with and those without MSI-H represent distinctive pathways of carcinogenesis, including aberrant expression of factors regulating angiogenesis. The difference may be associated with less aggressive phenotype of these cancers with MSI-H and affect future molecular targeted therapeutics.
巻・号 254(1)
ページ 42-53
公開日 2007-8-28
DOI 10.1016/j.canlet.2007.02.004
PII S0304-3835(07)00045-6
PMID 17374440
MeSH Angiogenic Proteins / genetics Angiogenic Proteins / metabolism Cell Line, Tumor Cyclooxygenase 2 / genetics Cyclooxygenase 2 / metabolism DNA Methylation DNA Mutational Analysis Female Fibroblast Growth Factor 2 / genetics Fibroblast Growth Factor 2 / metabolism Gene Expression Profiling* Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Kaplan-Meier Estimate Lymphatic Metastasis Male Microsatellite Instability* Multivariate Analysis Mutation Neovascularization, Pathologic / genetics Neovascularization, Pathologic / metabolism Neovascularization, Pathologic / pathology* Prognosis Receptors, G-Protein-Coupled Reverse Transcriptase Polymerase Chain Reaction Stomach Neoplasms / genetics Stomach Neoplasms / metabolism Stomach Neoplasms / pathology* Thrombospondin 1 / genetics Thrombospondin 1 / metabolism Tumor Suppressor Protein p53 / genetics Tumor Suppressor Protein p53 / metabolism Vascular Endothelial Growth Factor A / genetics Vascular Endothelial Growth Factor A / metabolism
IF 7.36
引用数 28
WOS 分野 ONCOLOGY
リソース情報
ヒト・動物細胞